PMV Pharmaceuticals, Inc
$1.50
Market Cap
$78.05M
Shares Outstanding
53.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 25, 2020
Round Lot
100
Locale
US
Day Open
$1.46
Day High
$1.52
Day Low
$1.43
Volume
1.18M
VWAP
$1.49
Prev Close
$1.46
Transactions
--
Acc. Volume
--
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.
PMV Pharmaceuticals, Inc (PMVP) closed the 2026-09-18 session at $1.50, up 2.74% versus the previous close (+0.04). The stock opened at $1.46 and traded between $1.43 and $1.52 during that session. Session trading volume was 1.2M shares. The volume-weighted average price (VWAP) is $1.49.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.
PMV Pharmaceuticals, Inc has a market capitalization of $78.0 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. PMVP is listed on the XNAS exchange. The company employs approximately 54 people. PMV Pharmaceuticals, Inc is headquartered in PRINCETON, NJ. The recorded listing date is 2020-09-25.
On this page you can find market PMVP stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.